Recurrent Breast Cancer Unknown Status Phase 2 Trials for Docetaxel (DB01248)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01351597A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast CancerTreatment